Search - tctmd.com

Displaying 121 - 140 of 571

Sort: Relevancy | Date

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 55: Incidence, Predictors, and Clinical Implications of Stent Optimization on Intravascular Ultrasound After New-generation Drug-eluting Stent Implantation for Diffuse Long Coronary Stenotic Lesions

Presenter: Byeong-Keuk Kim

September 25, 2019

Presentation TCT 2019

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

Presenter: Junjie Zhang

September 25, 2019

Presentation TCT 2019

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

Presenter: Takahiro Jimba

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Binita Shah

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Platforms and Outcomes 2019

Presenter: Roberto Diletti

September 25, 2019

Presentation EuroPCR 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Presenter: Clemens von Birgelen

May 21, 2019

Presentation EuroPCR 2019

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Presenter: Raban Jeger

May 20, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation SIF 2019

PCI vs. CABG for Multivessel CAD

Presenter: Sripal Bangalore

March 28, 2019

Presentation SIF 2019

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Presenter: Douglas E. Drachman

March 27, 2019

Presentation JIM 2019

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Presenter: Luca Testa

February 14, 2019

Presentation JIM 2019

Unmet Clinical Needs With Current Drug-Eluting Stents

Presenter: Davide Capodanno

February 14, 2019

Presentation TCT Abstracts Posters 2018

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Presenter: Hyungdon Kook

September 25, 2018

Presentation TCT Abstracts Posters 2018

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Presenter: Joel Lardizabal

September 25, 2018

Presentation TCT 2018

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

Presenter: Jeroen J. Bax, Seung-Jung Park

September 24, 2018

Presentation TCT 2018

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs

September 24, 2018

Presentation TCT 2018

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

Presenter: Jeroen J. Bax, Gert Richardt

September 24, 2018

Advertisement

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 55: Incidence, Predictors, and Clinical Implications of Stent Optimization on Intravascular Ultrasound After New-generation Drug-eluting Stent Implantation for Diffuse Long Coronary Stenotic Lesions

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Update: Drug-Eluting Stents

PCI vs. CABG for Multivessel CAD

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Unmet Clinical Needs With Current Drug-Eluting Stents

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content